[ORGANIZATION]
Agência Nacional de Vigilância Sanitária (Anvisa)
Featured in 18 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
336 clusters · 1253 sources · last updated
Latest: FDA requires vision-loss warnings for GLP-1 drugs
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Recent studies suggest these
Brazil ANVISA expands product safety enforcement
43 clusters · 290 sources · last updated
Latest: Anvisa bans Accu-Chek Active glucose test strips on Amazon
Since May 2026, Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics, and consumer goods. Early actions included suspending batches of statins
Also covered in
-
Lemongrass (Capim‑santo) Benefits Highlighted in Brazil
[HEALTH] · 2 sources ·
-
Anvisa suspends repellent lots and bans online dermatology products
[HEALTH] · 6 sources ·
-
Brazil's ANVISA Approves Tyvaso for Rare Pulmonary Hypertension
[HEALTH] · 6 sources ·
-
Brazil's Anvisa approves Kineret for rheumatoid arthritis and rare autoinflammatory diseases
[HEALTH] · 2 sources ·
-
São Paulo Pharmacy Council pushes prosecution over illegal drug vending machines
[HEALTH] · 8 sources ·
-
Anvisa approves Datroway for EGFR‑mutated advanced lung cancer
[HEALTH] · 26 sources ·
-
Brazil's ANVISA expands ozone therapy approvals for diabetic wound care
[HEALTH] · 2 sources ·